Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gastric Cancer
  Free Subscription

Articles published in
Anticancer Res
    September 2023
  1. IWASAKI H, Haraguchi E, Ihashi T, Yokomizo H, et al
    Risk Factor of Sarcopenia After Gastrectomy in Elderly Patients With Gastric Cancer.
    Anticancer Res. 2023;43:4207-4212.
    >> Share

    August 2023
  2. SHIMIZU S, Matsunaga T, Sawata S, Sakano YU, et al
    Preoperative Osteopenia Is a Risk Factor for Death in Patients Undergoing Gastrectomy for Gastric Cancer.
    Anticancer Res. 2023;43:3665-3672.
    >> Share

  3. ENDO S, Yamada T, Kawada J, Higashida M, et al
    Proximal Resection Line Determination Using Intraoperative Radiography in Laparoscopic Distal Gastrectomy for Gastric Cancer.
    Anticancer Res. 2023;43:3685-3691.
    >> Share

  4. TANAKA Y, Aoyagi K, Umetani Y, Tanaka YU, et al
    Impact of Skeletal Muscle Mass Reduction on Long-term Survival After Radical Resection of Gastric Cancer.
    Anticancer Res. 2023;43:3779-3786.
    >> Share

    July 2023
  5. ARIGAMI T, Matsushita D, Shimonosono M, Tsuruda Y, et al
    Clinical Significance of Recurrence Risk Score for Conversion Surgery in Patients With Advanced Gastric Cancer.
    Anticancer Res. 2023;43:3305-3310.
    >> Share

  6. KANAJI S, Urakawa N, Mukoyama T, Harada H, et al
    Safety of Laparoscopic Gastrectomy for Advanced Gastric Cancer With Greater than Serosal Invasion Depth.
    Anticancer Res. 2023;43:3145-3152.
    >> Share

  7. DAVAKIS S, Kapelouzou A, Sakellariou S, Kyriakoulis KG, et al
    Clinical and Oncological Impact of the Toll-like Receptor-3 and -4 in Esophageal and Gastro-esophageal Junction Adenocarcinoma.
    Anticancer Res. 2023;43:3183-3191.
    >> Share

  8. WOLL E, Amann A, Eisterer W, Gerger A, et al
    Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy - An Update.
    Anticancer Res. 2023;43:2889-2897.
    >> Share

    June 2023
  9. KOMORI K, Kano K, Ando S, Watanabe H, et al
    Clinicopathological Characteristics and Prognosis of Mucinous Gastric Cancer.
    Anticancer Res. 2023;43:2865-2871.
    >> Share

  10. SIHOMBING AM, Murata S, Shimoji M, Miyake T, et al
    CD44-positive Cancer Stem-like Cells as a Potential Source of Peritoneal Metastasis After Surgery.
    Anticancer Res. 2023;43:2491-2500.
    >> Share

  11. KASAHARA K, Kunisaki C, Sato S, Kondo H, et al
    Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer.
    Anticancer Res. 2023;43:2841-2850.
    >> Share

  12. ITO E, Ogino I, Sugiura M, Watanabe S, et al
    Long-term Outcomes of Early-stage Non-stomach Gastrointestinal Mucosa-associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy.
    Anticancer Res. 2023;43:2851-2857.
    >> Share

  13. HAYASHI K, Furuta M, Furusawa K, Hamaguchi T, et al
    Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer.
    Anticancer Res. 2023;43:2831-2840.
    >> Share

    May 2023
  14. MIYAMOTO H, Yoshii M, Tanaka H, Nishi S, et al
    Dorsal Subcutaneous Fat Thickness as a Risk Factor for Pancreatic Fistula After Gastric Cancer Surgery.
    Anticancer Res. 2023;43:2171-2178.
    >> Share

  15. ITO S, Ohgaki K, Kawazoe T, Sato S, et al
    Survival Benefits of Laparoscopic Gastrectomy in Elderly Patients With Gastric Cancer: Focusing on Preoperative Nutritional and Inflammatory Status.
    Anticancer Res. 2023;43:2055-2067.
    >> Share

  16. YUKAWA N, Yamada T, Aoyama T, Woo T, et al
    Tumor DNA in Peritoneal Lavage as a Novel Biomarker for Predicting Peritoneal Recurrence in Patients With Gastric Cancer.
    Anticancer Res. 2023;43:2069-2076.
    >> Share

  17. MORINO K, Yamamoto M, Yamanaka R, Iwasaki Y, et al
    Clinical Impact of Laparoscopic Surgery on the Long-term Survival of Advanced Gastric Cancer Patients With Regard to Facilitating Doublet Adjuvant Chemotherapy.
    Anticancer Res. 2023;43:2203-2209.
    >> Share

    April 2023
  18. YANG YM, Ruge F, Ji KE, Jia S, et al
    ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient's Response to Chemotherapies.
    Anticancer Res. 2023;43:1463-1475.
    >> Share

  19. OTSUKA R, Morishita H, Iida K, Hayano K, et al
    Serum Versus Tissue SIRT1 as Potentially Valuable Biomarkers in Gastric Cancer.
    Anticancer Res. 2023;43:1485-1491.
    >> Share

  20. HASHIMOTO I, Kano K, Onuma S, Suematsu H, et al
    Clinical Significance of Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients With Metastatic Gastric or Gastroesophageal Junction Cancer Administered Trifluridine/Tipiracil.
    Anticancer Res. 2023;43:1689-1697.
    >> Share

  21. AYUB A, Naeem B, Perez A, Tyler D, et al
    Gastric Linitis Plastica: Clinical Characteristics and Outcomes from the National Cancer Database.
    Anticancer Res. 2023;43:1543-1548.
    >> Share

    February 2023
  22. AOYAMA T, Hara K, Maezawa Y, Kazama K, et al
    Clinical Course of Vitamin B12 Deficiency and Associated Risk Factors in Patients After Total Gastrectomy for Gastric Cancer.
    Anticancer Res. 2023;43:689-694.
    >> Share

  23. UEHARA H, Ota M, Yamamoto M, Nakanoko T, et al
    Prognostic Significance of Preoperative Nutritional Assessment in Elderly Patients who Underwent Laparoscopic Gastrectomy for Stage I-III Gastric Cancer.
    Anticancer Res. 2023;43:893-901.
    >> Share

  24. SHIBAMOTO J, Kubota T, Nishibeppu K, Ohashi T, et al
    Clinical Relevance of Proximal Gastrectomy With Double-flap Esophagogastrostomy Reconstruction With Glycemic Profile and Postgastrectomy Syndromes.
    Anticancer Res. 2023;43:857-864.
    >> Share

  25. NAKAZAWA N, Sohda M, Tateno K, Watanabe T, et al
    Examining the Efficacy of Nivolumab for Gastric Cancer Focusing on Using an Inflammation-based Prognostic Score: A Multicenter Retrospective Study.
    Anticancer Res. 2023;43:927-934.
    >> Share

  26. YAMAMOTO A, Shoda K, Kawaguchi Y, Akaike H, et al
    The Prognostic Implications of Perioperative Serum Cholesterol Levels in Patients With Gastric Cancer.
    Anticancer Res. 2023;43:903-909.
    >> Share

    January 2023
  27. NAMIKAWA T, Utsunomiya M, Yokota K, Munekage M, et al
    Staple Line Reinforcement for Intracorporeal Anastomosis Reduces Time for Reconstruction During Laparoscopic Gastrectomy for Gastric Cancer.
    Anticancer Res. 2023;43:175-181.
    >> Share

  28. HU Y, Huang L, Zhao K, Li Y, et al
    CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
    Anticancer Res. 2023;43:115-126.
    >> Share

  29. KUWADA K, Kikuchi S, Kuroda S, Yoshida R, et al
    Survival Impact of Postoperative Skeletal Muscle Loss in Gastric Cancer Patients Who Underwent Gastrectomy.
    Anticancer Res. 2023;43:223-230.
    >> Share

    December 2022
  30. SUEMATSU H, Sakamaki K, Oue N, Hiroshima Y, et al
    Clinical Significance of SEC11A Expression in Patients With Locally Advanced Gastric Cancer.
    Anticancer Res. 2022;42:5885-5890.
    >> Share

  31. SAKAGUCHI M, Hosogi H, Hisamori S, Kinjo Y, et al
    Limited Oncological Benefits of Laparoscopic Total Gastrectomy With Splenectomy for Patients With Type 4 or Large Type 3 Gastric Cancer.
    Anticancer Res. 2022;42:5937-5944.
    >> Share

  32. SUGEZAWA K, Morimoto M, Yamamoto M, Matsumi Y, et al
    GPX4 Regulates Tumor Cell Proliferation via Suppressing Ferroptosis and Exhibits Prognostic Significance in Gastric Cancer.
    Anticancer Res. 2022;42:5719-5729.
    >> Share

    November 2022
  33. AOYAMA T, Hara K, Kazama K, Maezawa Y, et al
    Clinical Impact of Nutrition and Inflammation Assessment Tools in Gastric Cancer Treatment.
    Anticancer Res. 2022;42:5167-5180.
    >> Share

  34. SERA T, Sakuma T, Maruo K, Tsujio G, et al
    Candidate Oncogenes, ARHGAP4, NOS3, and OR51B5, for the Development of Scirrhous-type Gastric Cancer.
    Anticancer Res. 2022;42:5195-5203.
    >> Share

  35. KOMATSU M, Kinoshita T, Akimoto E, Yoshida M, et al
    The Significance of Staging Laparoscopy in Detection of Radiologically Occult Peritoneal Carcinomatosis in Gastric Cancer With Gastric Outlet Obstruction: Consideration of The Optimal Treatment Approach.
    Anticancer Res. 2022;42:5571-5578.
    >> Share

    October 2022
  36. MATSUI R, Inaki N, Tsuji T, Fukunaga T, et al
    Relationship Between Fat Mass Indices and Postoperative Complications After Laparoscopic Gastrectomy in Patients With Gastric Cancer: A Propensity Score Matching Analysis.
    Anticancer Res. 2022;42:4841-4848.
    >> Share

  37. MATSUOKA H, Mizuno T, Sakai M, Suzuki K, et al
    The Effect and Tolerability of Second-line Chemotherapy Are Associated With Disease Control by Nivolumab Chemotherapy in Patients With Gastric Cancer.
    Anticancer Res. 2022;42:4973-4980.
    >> Share

  38. JANG H, Seo AN, Kim M
    Clinicopathological Characteristics of Advanced Epstein-Barr Virus-associated Gastric Cancer Highlighting Aberrant p53 Expression.
    Anticancer Res. 2022;42:4955-4962.
    >> Share

    September 2022
  39. FUJII H, Sadaka S, Ajisawa K, Okumura N, et al
    Association Between Peripheral Neuropathy Induced by Oxaliplatin at First-line Chemotherapy and Efficacy of Paclitaxel at Second-line Chemotherapy in Patients With Advanced Gastric Cancer.
    Anticancer Res. 2022;42:4581-4588.
    >> Share

  40. MATSUI R, Inaki N, Tsuji T
    Impact of GLIM Defined Malnutrition on Long Term Prognosis in Patients With Gastric Cancer After Gastrectomy.
    Anticancer Res. 2022;42:4611-4618.
    >> Share

  41. KOMORI K, Kano K, Aoyama T, Hara K, et al
    Clinical Impact of Surgical Sarcopenia on Long-term Survival.
    Anticancer Res. 2022;42:4545-4552.
    >> Share

  42. PEREIRA BS, Wisnieski F, Calcagno DQ, Santos LC, et al
    Genetic and Transcriptional Analysis of 8q24.21 Cluster in Gastric Cancer.
    Anticancer Res. 2022;42:4381-4394.
    >> Share

    August 2022
  43. JU M, Aoyama T, Komori K, Tamagawa H, et al
    The Albumin-Bilirubin Score Is a Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
    Anticancer Res. 2022;42:3929-3935.
    >> Share

  44. AOYAMA T, Maezawa Y, Cho H, Saigusa Y, et al
    Phase II Study of a Multi-center Randomized Controlled Trial to Evaluate Oral Vitamin B12 Treatment for Vitamin B12 Deficiency After Total Gastrectomy in Gastric Cancer Patients.
    Anticancer Res. 2022;42:3963-3970.
    >> Share

  45. SUEMATSU H, Hashimoto I, Hiroshima Y, Watanabe H, et al
    Clinical Significance of EREG Gene Expression in Gastric Cancer Tissue After Curative Surgery.
    Anticancer Res. 2022;42:3873-3878.
    >> Share

  46. KAKU H, Aoyagi K, Sudo T, Tanaka Y, et al
    Significance of Intraperitoneal-free KRT20 and CEACAM6 mRNA Expression for Peritoneal Recurrence of Gastric Cancer.
    Anticancer Res. 2022;42:4003-4010.
    >> Share

    July 2022
  47. KIKUCHI S, Takata N, Kuroda S, Umeda H, et al
    Impact of Amino Acids Nutrition Following Gastrectomy in Gastric Cancer Patients.
    Anticancer Res. 2022;42:3637-3643.
    >> Share

  48. TAKABATAKE K, Konishi H, Kubota T, Shiozaki A, et al
    Postoperative Nutrition Status of Patients With Esophago-gastric Junction Cancer With Gastric Tube or Esophago-gastric Reconstruction.
    Anticancer Res. 2022;42:3645-3652.
    >> Share

    June 2022
  49. BOOKA E, Kikuchi H, Haneda R, Soneda W, et al
    Neutrophil-to-Lymphocyte Ratio to Predict the Efficacy of Immune Checkpoint Inhibitor in Upper Gastrointestinal Cancer.
    Anticancer Res. 2022;42:2977-2987.
    >> Share

  50. OH SE, Oh MY, Kim SM, Kim SY, et al
    Feasibility of Gastric Tumor Xenograft (GTX)-derived Cell Lines for Individualized Anti-cancer Drug Screening.
    Anticancer Res. 2022;42:2883-2891.
    >> Share

    May 2022
  51. CHIN K, Takahari D, Kawabata R, Hosaka H, et al
    Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial.
    Anticancer Res. 2022;42:2683-2687.
    >> Share

  52. KOMORI K, Kano K, Yamada T, Watanabe H, et al
    Usefulness of Surgical Staging of Gastric Cancer in Neoadjuvant Chemotherapy Candidates: A Single-center Retrospective Study.
    Anticancer Res. 2022;42:2719-2725.
    >> Share

  53. VIRGILIO E, Montali F, Annicchiarico A, Salvemini C, et al
    Exosomal Functional Cargoes from Liquid Biopsy of Gastric Cancer: A Systematic Review of Studies With Potential Clinical Relevance.
    Anticancer Res. 2022;42:2249-2259.
    >> Share

    April 2022
  54. HANAKI T, Sunaguchi T, Goto K, Morimoto M, et al
    The Significance of Surgical Intervention for Metasynchronous Liver Metastasis in Gastric Cancer: A Single-centre Analysis.
    Anticancer Res. 2022;42:2177-2184.
    >> Share

  55. YOSHIOKA T, Takahashi M, Sakamoto Y, Okita A, et al
    Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial.
    Anticancer Res. 2022;42:2009-2015.
    >> Share

  56. FU CK, Mong MC, Yu CC, Yang MD, et al
    Association of Matrix Metallopeptidase-2 Genotypes With Risk of Gastric Cancer in Taiwan.
    Anticancer Res. 2022;42:1749-1755.
    >> Share

  57. ISHIKAWA A, Kuraoka K, Zaitsu J, Saito A, et al
    Transcriptomic Analysis of Annexin A10 and Chemosensitivity in Gastric Adenocarcinoma Cells.
    Anticancer Res. 2022;42:1707-1717.
    >> Share

    March 2022
  58. MASUDA Y, Kananazawa Y, Matsuno K, Kakinuma D, et al
    Impact of Second-line Chemotherapy on Prognosis: Response of Advanced Gastric Cancer to Taxanes Plus Ramucirumab.
    Anticancer Res. 2022;42:1599-1605.
    >> Share

  59. SUZUKI S, Urakawa N, Hasegawa H, Kanaji S, et al
    Prognostic Predictors After Surgical Intervention for Stage IV Gastric Cancer.
    Anticancer Res. 2022;42:1541-1546.
    >> Share

  60. SUEMATSU H, Kano K, Yamada T, Hashimoto I, et al
    Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab.
    Anticancer Res. 2022;42:1535-1540.
    >> Share

    February 2022
  61. URAKAWA N, Kanaji S, Suzuki S, Sawada R, et al
    Prognostic and Clinicopathological Significance of Lymph Node Metastasis in the Esophagogastric Junction Adenocarcinoma.
    Anticancer Res. 2022;42:1051-1057.
    >> Share

    January 2022
  62. MOON SH, Park NS, Noh MH, Kim YS, et al
    Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells.
    Anticancer Res. 2022;42:555-563.
    >> Share

  63. JUNG JY, Koh SA, Lee KH, Kim JR, et al
    14-3-3 Sigma Protein Contributes to Hepatocyte Growth Factor-mediated Cell Proliferation and Invasion via Matrix Metalloproteinase-1 Regulation in Human Gastric Cancer.
    Anticancer Res. 2022;42:519-530.
    >> Share

  64. KUSHIYAMA S, Yashiro M, Yamamoto Y, Sera T, et al
    Dipeptidyl Peptidase-4 from Cancer-associated Fibroblasts Stimulates the Proliferation of Scirrhous-type Gastric Cancer Cells.
    Anticancer Res. 2022;42:501-509.
    >> Share

  65. TAKASHIMA Y, Komatsu S, Kasuga M, Ohashi T, et al
    Tumor Location on the Vertical Section of the Anterior Wall Is Related to Favorable Prognosis and Low Incidence of Lymph Node Metastasis in Lower-third Gastric Cancer.
    Anticancer Res. 2022;42:237-243.
    >> Share

  66. AURELLO P, Minervini A, Pace M, D'Angelo F, et al
    The Role of Surgery in the Treatment of Metachronous Liver Metastasis from Gastric Cancer: A Systematic Review.
    Anticancer Res. 2022;42:25-33.
    >> Share

  67. YANG JS, Kang CY, Su CH, Chen CJ, et al
    Helicobacter pylori Targets in AGS Human Gastric Adenocarcinoma: In Situ Proteomic Profiling and Systematic Analysis.
    Anticancer Res. 2022;42:531-546.
    >> Share

  68. MIYATA H, Akiyama Y, Iizuka A, Kondou R, et al
    Development of an Automatic Measurement Method for CD8 and PD-1 Positive T Cells Using Image Analysis Software.
    Anticancer Res. 2022;42:419-427.
    >> Share

  69. QUESADA S, Samalin E, Thezenas S, Khellaf L, et al
    Perioperative FOLFOX in Patients With Locally Advanced Oesogastric Adenocarcinoma.
    Anticancer Res. 2022;42:185-193.
    >> Share

    November 2021
  70. CHANG K, Song B, DO IG, Koo DH, et al
    Venous Invasion and Perineural Invasion as Upstaging and Poor Prognostic Factors in N0 Gastric Cancers.
    Anticancer Res. 2021;41:5803-5810.
    >> Share

  71. OKUBO K, Arigami T, Matsushita D, Uenosono Y, et al
    The Clinical Significance of CA19-9 and Tumor Size Ratios for Predicting Prognosis After Conversion Surgery in Patients With Stage IV Gastric Cancer.
    Anticancer Res. 2021;41:5643-5649.
    >> Share

  72. AOYAMA T, Nakazono M, Segami K, Nagasawa S, et al
    Safety and Feasibility of Gastrectomy for Gastric Cancer in Patients Receiving Antiplatelet and/or Anticoagulation Treatment.
    Anticancer Res. 2021;41:5605-5610.
    >> Share

  73. MA YE, Liang X, Liu LI, Gao D, et al
    Survival Response of Patients With Gastric Cancer Treated With Regional Arterial-Perfusion Chemotherapy Is Correlated With Borrmann Classification.
    Anticancer Res. 2021;41:5507-5515.
    >> Share

  74. TSUJIYA Y, Yamamori M, Hasegawa AI, Yamamoto Y, et al
    Telmisartan Exerts Cytotoxicity in Scirrhous Gastric Cancer Cells by Inducing G0/G1 Cell Cycle Arrest.
    Anticancer Res. 2021;41:5461-5468.
    >> Share

    September 2021
  75. KOH SA, Lee KH
    HGF-mediated Up-regulation of PHLDA2 Is Associated With Apoptosis in Gastric Cancer.
    Anticancer Res. 2021;41:4377-4385.
    >> Share

  76. CHEN HY, Yang MD, Chou YC, Ma YS, et al
    Ouabain Suppresses Cell Migration and Invasion in Human Gastric Cancer AGS Cells Through the Inhibition of MMP Signaling Pathways.
    Anticancer Res. 2021;41:4365-4375.
    >> Share

  77. WEIDLE UH, Birzele F, Auslaender S, Brinkmann U, et al
    Down-regulated MicroRNAs in Gastric Carcinoma May Be Targets for Therapeutic Intervention and Replacement Therapy.
    Anticancer Res. 2021;41:4185-4202.
    >> Share

    August 2021
  78. HAN SH, Han JH, Han SH, Kim HS, et al
    Fixation Using Carnoy's Solution Enables Detection of More Lymph Nodes After Gastrectomy for Gastric Cancer.
    Anticancer Res. 2021;41:3949-3953.
    >> Share

  79. NAKAZAWA N, Sohda M, Yamaguchi A, Watanabe T, et al
    An Elevated Serum Lactate Dehydrogenase-to-albumin Ratio Is a Useful Poor Prognostic Predictor of Nivolumab in Patients With Gastric Cancer.
    Anticancer Res. 2021;41:3925-3931.
    >> Share

  80. MATSUMOTO T, Toya R, Shimohigashi Y, Watakabe T, et al
    Plan Quality Comparisons Between 3D-CRT, IMRT, and VMAT Based on 4D-CT for Gastric MALT Lymphoma.
    Anticancer Res. 2021;41:3941-3947.
    >> Share

    July 2021
  81. HYUN CL, Park SJ, Kim HS, Song HJ, et al
    The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
    Anticancer Res. 2021;41:3689-3698.
    >> Share

  82. HATORI S, Sakamaki K, Yokohori T, Kimura Y, et al
    Clinical Significance of PLA2G2A Expression in Gastric Cancer Patients who Receive Gastrectomy and Adjuvant S-1.
    Anticancer Res. 2021;41:3583-3588.
    >> Share

  83. KULIG P, Nowakowski P, Sierzega M, Pach R, et al
    Analysis of Prognostic Factors Affecting Short-term and Long-term Outcomes of Gastric Cancer Resection.
    Anticancer Res. 2021;41:3523-3534.
    >> Share

  84. AKANDA MR, Park JS, Noh MG, Ha GH, et al
    TACC3 Promotes Gastric Carcinogenesis by Promoting Epithelial-mesenchymal Transition Through the ERK/Akt/cyclin D1 Signaling Pathway.
    Anticancer Res. 2021;41:3349-3361.
    >> Share

  85. FU CK, Chang WS, Tsai CW, Wang YC, et al
    The Association of MMP9 Promoter Rs3918242 Genotype With Gastric Cancer.
    Anticancer Res. 2021;41:3309-3315.
    >> Share

    June 2021
  86. ARIGAMI T, Matsushita D, Okubo K, Sasaki K, et al
    Prognostic Significance of HER2 Expression for Gastric Cancer With Clinically Para-aortic Lymph Node Metastasis.
    Anticancer Res. 2021;41:3099-3107.
    >> Share

    May 2021
  87. TSAI CY, Liu KH, Chiu CT, Hsueh SW, et al
    Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
    Anticancer Res. 2021;41:2711-2718.
    >> Share

  88. TAKAO K, Konishi H, Matsubara D, Shoda K, et al
    MiR-3663-3p Inhibits the Progression of Gastric Cancer Through the CCND1 Pathway.
    Anticancer Res. 2021;41:2441-2449.
    >> Share

    April 2021
  89. JIN YZ, Gong YX, Liu Y, Xie DP, et al
    Peroxiredoxin V Silencing Elevates Susceptibility to Doxorubicin-induced Cell Apoptosis via ROS-dependent Mitochondrial Dysfunction in AGS Gastric Cancer Cells.
    Anticancer Res. 2021;41:1831-1840.
    >> Share

    March 2021
  90. NAKANISHI Y, Hirota S, Hojo Y, Nakamura T, et al
    Pathological Complete Remission of Liver Metastases Correlates With Elimination of Tumor-infiltrating Tregs in Gastric Cancer.
    Anticancer Res. 2021;41:1571-1577.
    >> Share

  91. ZHANG X, Yamamoto Y, Wang X, Sato M, et al
    MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53.
    Anticancer Res. 2021;41:1475-1483.
    >> Share

    February 2021
  92. SHIMODA Y, Fujikawa H, Komori K, Watanabe H, et al
    Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery.
    Anticancer Res. 2021;41:1005-1012.
    >> Share

  93. SUZUKI O, Yamaguchi T, Fukuchi M, Mochiki E, et al
    Prediction Model for Gastric Cancer With DNA Mismatch Repair Deficiency.
    Anticancer Res. 2021;41:975-982.
    >> Share

  94. SASAHARA M, Kanda M, Shimizu D, Tanaka C, et al
    Tissue RNFT2 Expression Levels Are Associated With Peritoneal Recurrence and Poor Prognosis in Gastric Cancer.
    Anticancer Res. 2021;41:609-617.
    >> Share

    January 2021
  95. KIM EJ, Kim M, Seo S, Kim MJ, et al
    Comparison of Sinusoidal Obstruction Syndrome in Gastric Cancer Patients Receiving S-1/oxaliplatin Versus Capecitabine/oxaliplatin.
    Anticancer Res. 2021;41:391-402.
    >> Share

  96. LIM SC, Lee TB, Kang BS, Iy Han S, et al
    Extracellular Acidity-mediated Expression of cPLA2gamma Confers Resistance in Gastric Cancer Cells.
    Anticancer Res. 2021;41:211-218.
    >> Share

  97. LEE GH, Park JW, Roh J, Kim YB, et al
    Association Between Waiting Time from Diagnosis to Endoscopic Submucosal Dissection and Non-curative Resection in Gastric Neoplasm.
    Anticancer Res. 2021;41:459-466.
    >> Share

    December 2020
  98. FUJII H, Makiyama A, Iihara H, Okumura N, et al
    Cancer Cachexia Reduces the Efficacy of Nivolumab Treatment in Patients With Advanced Gastric Cancer.
    Anticancer Res. 2020;40:7067-7075.
    >> Share

  99. NAKAMURA S, Kanda M, Shimizu D, Tanaka C, et al
    AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer.
    Anticancer Res. 2020;40:6713-6721.
    >> Share

    November 2020
  100. TRUMBULL D, Lemini R, Attwood K, Kukar M, et al
    Gastric Cancer Disparities Among Asian American Subpopulations.
    Anticancer Res. 2020;40:6381-6385.
    >> Share

  101. CHEN YC, Wu CC, Tu YT, Chen YR, et al
    Involvement of the MicroRNA-1-LITAF Axis in Gastric Cancer Cell Growth and Invasion.
    Anticancer Res. 2020;40:6247-6256.
    >> Share

  102. MAKI M, SOderstrOm D, Paloheimo L, Hendolin P, et al
    Helicobacter pylori (Hp) IgG ELISA of the New-Generation GastroPanel(R) Is Highly Accurate in Diagnosis of Hp-Infection in Gastroscopy Referral Patients.
    Anticancer Res. 2020;40:6387-6398.
    >> Share

    October 2020
  103. HASHIMOTO I, Oue N, Kimura Y, Hiroshima Y, et al
    Clinical Significance of Glioma-associated Oncogene 1 Expression in Patients With Locally Advanced Gastric Cancer Administered Adjuvant Chemotherapy With S-1 After Curative Surgery.
    Anticancer Res. 2020;40:5815-5821.
    >> Share

  104. ENDO S, Fujiwara Y, Yamatsuji T, Nishikawa K, et al
    Is it Necessary to Confirm Negative Margins in Gastrectomy for Peritoneal Lavage Cytology-positive Gastric Cancer?
    Anticancer Res. 2020;40:5807-5813.
    >> Share

  105. UEJIMA C, Morimoto M, Yamamoto M, Hara K, et al
    Prognostic Significance of TYRO3 Receptor Tyrosine Kinase Expression in Gastric Cancer.
    Anticancer Res. 2020;40:5593-5600.
    >> Share

  106. SUGISAWA N, Nishino H, Higuchi T, Park JH, et al
    A Gemcitabine Plus 5-Fluorouracil Combination Inhibits Gastric-Cancer Liver Metastasis in a PDOX Model: A Novel Treatment Strategy.
    Anticancer Res. 2020;40:5393-5397.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016